Citation Impact
Citing Papers
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
2021 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
2003 StandoutScience
New Insights into the Role of RNase L in Innate Immunity
2010
Hallmarks of Cancer: The Next Generation
2011 Standout
TLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases
2009
Inflammation and cancer
2002 StandoutNature
Positional cloning moves from perditional to traditional
1995
Microsatellite Instability in Colorectal Cancer
2010 Standout
Variation in Antiviral 2′,5′-Oligoadenylate Synthetase (2′5′AS) Enzyme Activity Is Controlled by a Single-Nucleotide Polymorphism at a Splice-Acceptor Site in the OAS1 Gene
2005
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
2003 StandoutNature
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
2001
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
2000
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
The GRK4 Subfamily of G Protein-coupled Receptor Kinases
1999 StandoutNobel
Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
1994 StandoutNature
Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
1994
Akt-regulated pathways in prostate cancer
2005
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
1994 Nature
Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
The Human Transcription Factors
2018 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
The Epigenomics of Cancer
2007 Standout
New advances in our understanding of the “unique” RNase L in host pathogen interaction and immune signaling
2016
Mutation analysis and molecular genetics of epidermolysis bullosa
1999
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Global cancer statistics
2011 Standout
Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice
1996 Standout
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
2007
The role of enhancers in cancer
2016
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
Radiation hybrids: irradiation and fusion gene transfer
1993
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
2010 Nature
Immunity, Inflammation, and Cancer
2010 Standout
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy
2010
Characterization of the G Protein-coupled Receptor Kinase GRK4
1996 StandoutNobel
Results from a prostate cancer admixture mapping study in African-American men
2009
A Novel Multiple PDZ Domain-containing Molecule Interacting withN-Methyl-d-aspartateReceptors and Neuronal Cell Adhesion Proteins
1998 StandoutNobel
A Convenient and Sensitive Fluorescence Resonance Energy Transfer Assay for RNase L and 2′,5′ Oligoadenylates
2005
Nucleic acid‐mediated inflammatory diseases
2008
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma
2010
RNase L: Its biological roles and regulation
2006
Synteny conservation of the Huntington's disease gene and surrounding loci on mouse Chromosome 5
1994
Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells
2008
Integrins
2002 Standout
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction
1992
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
2010 StandoutScience
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Cancer of the Ovary
2004 Standout
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
2004
Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities
2015
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L
2005
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
1998
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
1996 StandoutScience
Comparative sequence analysis of the human and pufferfish Huntington's disease genes
1995 StandoutNobel
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
1993 Standout
Neural Science
2000 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Regional analysis ofp53mutations in rheumatoid arthritis synovium
2002
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
1997
Site-Specific Cleavage of Human Chromosome 4 Mediated by Triple-Helix Formation
1991 Science
Podocalyxin Increases the Aggressive Phenotype of Breast and Prostate Cancer Cells In vitro through Its Interaction with Ezrin
2007
Neuroscience: Breaking Down Scientific Barriers to the Study of Brain and Mind
2000 StandoutScienceNobel
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
1996 StandoutScience
Interferons, immunity and cancer immunoediting
2006
Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein
1996 StandoutScience
The Human Genome Project: Reaching the Finish Line
1998 StandoutScienceNobel
Chemical Glycoproteomics
2016 StandoutNobel
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of Sarah J. Plummer being referenced
Germline BRCA1 Alterations in a Population-Based Series of Ovarian Cancer Cases
1999
Toll-Like Receptor 4 Genetic Variation and Advanced Prostate Cancer Risk
2007
Reduced expression of autotaxin predicts survival in uveal melanoma
2007
A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4
1991
Radiation hybrid map spanning the huntington disease gene region of chromosome 4
1992
Sequence-tagged sites (STSs) spanning 4p16.3 and the Huntington disease candidate region
1992
Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25
1997
Podocalyxin variants and risk of prostate cancer and tumor aggressiveness
2006
Multiple Functional Risk Variants in a SMAD7 Enhancer Implicate a Colorectal Cancer Risk Haplotype
2014
Detection of BRCA1 mutations by the protein truncation test
1995
Quality Assessment and Correlation of Microsatellite Instability and Immunohistochemical Markers among Population- and Clinic-Based Colorectal Tumors
2011
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
2002
Nonsteroidal Antiinflammatory Drugs and Decreased Risk of Advanced Prostate Cancer: Modification by Lymphotoxin Alpha
2006
A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
1994
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
2003